Treatment patterns of multiple sclerosis patients treated with disease-modifying therapies in Puerto Rico

被引：0
|
作者：
Chia, J. [1 ]
Nunez, M. [1 ]
Hernandez, H. [2 ]
Jimenez, G. [2 ]
Ong, A. [1 ]
Hashemi, L. [1 ]
机构：
[1] Sanofi, Cambridge, MA USA
[2] Special Care Pharm Serv, San Juan, PR USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
v
引用
收藏
页码：764 / 764
页数：1
相关论文
共 50 条
  • [41] Assessing the risk of multiple sclerosis disease-modifying therapies
    Ayrignac, Xavier
    Bilodeau, Philippe-Antoine
    Prat, Alexandre
    Girard, Marc
    Labauge, Pierre
    Le Lorier, Jacques
    Larochelle, Catherine
    Duquette, Pierre
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (07) : 695 - 706
  • [42] Impact of Disease-Modifying Therapies on Fatigue in Multiple Sclerosis
    Voelter, H. U.
    Hildebrandt, H.
    Kastrup, A.
    AKTUELLE NEUROLOGIE, 2016, 43 (08) : 511 - 518
  • [43] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Benedikt Kretzschmar
    Hannah Pellkofer
    Martin S. Weber
    Current Neurology and Neuroscience Reports, 2016, 16
  • [44] Current and future disease-modifying therapies in multiple sclerosis
    Lim, S. Y.
    Constantinescu, C. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 637 - 650
  • [45] Disease-modifying therapies and infectious risks in multiple sclerosis
    Winkelmann, Alexander
    Loebermann, Micha
    Reisinger, Emil C.
    Hartung, Hans-Peter
    Zettl, Uwe K.
    NATURE REVIEWS NEUROLOGY, 2016, 12 (04) : 217 - 233
  • [46] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [47] Disease-modifying therapies and infectious risks in multiple sclerosis
    Alexander Winkelmann
    Micha Loebermann
    Emil C. Reisinger
    Hans-Peter Hartung
    Uwe K. Zettl
    Nature Reviews Neurology, 2016, 12 : 217 - 233
  • [48] Outpatient infections, multiple sclerosis and disease-modifying therapies
    Langer-Gould, A.
    Smith, J. B.
    Piehl, F.
    Li, B. H.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 635 - 636
  • [49] Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
    Porwal, Mokshal H.
    Salter, Amber
    Patel, Dhruvkumar
    Obeidat, Ahmed Z.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2022, 14
  • [50] Treatment Patterns Among Patients With Multiple Sclerosis Newly Initiating Disease-Modifying Therapy
    Freeman, Leorah
    Mehta, Rina
    Tian, Marc
    Pelletier, Corey
    NEUROLOGY, 2020, 94 (15)
12345